×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 10: Post-Approval Changes (CMC, Manufacturing, and Labeling)
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- Device supplements
- Drug supplements
- Application to Combination Products
- Device and Drug Changes Made to Products Approved via PMA
- Device and Drug Changes Made to Products Approved via NDA
Have an account?